Chemical versus Mechanical and Chemical Venous Thromboembolism Prophylaxis in Neurocritically Ill Patients: A Cohort Study

References

• Betthauser K, Pope H, Gowan M, Human T. Practice patterns of venous thromboembolism prophylaxis in underweight, critically ill patients with neurologic injury. Neurocrit Care. 2017;27(1):96–102. doi:10.1007/s12028-016-0373-4
   Web of Science ®Google Scholar
• Nyquist P, Bautista C, Jichici D, et al. Prophylaxis of venous thrombosis in neurocritical care patients, an evidence-based guideline, a statement for healthcare professionals from the neurocritical care society. Neurocrit Care. 2016;24(1):47–60. doi:10.1007/s12028-015-0221-y
   Web of Science ®Google Scholar
• Deitelzweig SB, Johnson BH, Lin J, Schulman KL. Prevalence of clinical venous thromboembolism in the USA, current trends and future projections. Am J Hematol. 2011;86(2):217–220. doi:10.1002/ajh.21917
   PubMed Web of Science ®Google Scholar
• Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98(4):756–764. doi:10.1160/TH07-03-0212
   PubMed Web of Science ®Google Scholar
• Douds GL, Hellkamp AS, Olson DM, et al. Venous thromboembolism in the get with the guidelines-stroke acute ischemic stroke population, incidence and patterns of prophylaxis. J Stroke Cerebrovasc Dis. 2014;23(1):123–129. doi:10.1016/j.jstrokecerebrovasdis.2012.10.018
   Web of Science ®Google Scholar
• Skaf E, Stein PD, Beemath A, Sanchez J, Bustamante MA, Olson RE. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol. 2005;96(12):1731–1733. doi:10.1016/j.amjcard.2005.07.097
   PubMed Web of Science ®Google Scholar
• Goldstein JN, Fazen LE, Wendell L, et al. Risk of thromboembolism following acute intracerebral hemorrhage. Neurocrit Care. 2009;10(1):28–34. doi:10.1007/s12028-008-9134-3
   PubMed Web of Science ®Google Scholar
• Minet C, Potton L, Bonadona A, et al. Venous thromboembolism in the ICU, main characteristics, diagnosis and thromboprophylaxis. Crit Care. 2015;19(1):287. doi:10.1186/s13054-015-1003-9
   PubMedGoogle Scholar
• Reiff DA, Haricharan RN, Bullington NM, Griffin RL, McGwin G, Rue LW. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma. 2009;66(5):1436–1440. doi:10.1097/TA.0b013e31817fdf1c
   Google Scholar
• Amin A, Hussein M, Battleman D, Lin J, Stemkowski S, Merli GJ. Appropriate VTE prophylaxis is associated with lower direct medical costs. Hosp Pract. 2010;38(4):130–137. doi:10.3810/hp.2010.11.350
   Google Scholar
• Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients, antithrombotic therapy and prevention of thrombosis, 9th ed, American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2Suppl):e195S–e226S. doi:10.1378/chest.11-2296
   PubMedGoogle Scholar
• Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med. 1982;10(7):448–450. doi:10.1097/00003246-198207000-00006
   PubMed Web of Science ®Google Scholar
• Fraisse F, Holzapfel L, Couland JM, et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The association of non-university affiliated intensive care specialist physicians of France. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1109–1114. doi:10.1164/ajrccm.161.4.9807025
   PubMed Web of Science ®Google Scholar
• Dennis M, Sandercock P, Graham C, Forbes J. CLOTS (clots in legs or stockings after stroke) trials collaboration, smith j. the clots in legs or stockings after stroke (CLOTS) 3 trial, a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness. Health Technol Assess. 2015;19(76):1–90.
   Web of Science ®Google Scholar
• Carney N, Totten AM, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury. Neurosurgery. 2017;80(1):6–15. doi:10.1227/NEU.0000000000001432
   PubMed Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke, 2019 update to the 2018 guidelines for the early management of acute ischemic stroke, a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–e418. doi:10.1161/STR.0000000000000211
   PubMed Web of Science ®Google Scholar
• Dennis M, Sandercock P; CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3), a multicentre randomised controlled trial. Lancet. 2013;382(9891):516–524.
   Web of Science ®Google Scholar
• Prabhakaran S, Herbers P, Khoury J, et al. Is prophylactic anticoagulation for deep venous thrombosis common practice after intracerebral hemorrhage? Stroke. 2015;46(2):369–375. doi:10.1161/STROKEAHA.114.008006
   PubMed Web of Science ®Google Scholar
• Liang CW, Su K, Liu JJ, Dogan A, Hinson HE. Timing of deep vein thrombosis formation after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2015;123(4):891–896. doi:10.3171/2014.12.JNS141288
   Web of Science ®Google Scholar
• Paciaroni M, Agnelli G, Venti M, Alberti A, Acciarresi M, Caso V. Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage, a meta-analysis of controlled studies. J Thromb Haemost. 2011;9(5):893–898. doi:10.1111/j.1538-7836.2011.04241.x
   PubMed Web of Science ®Google Scholar
• Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease, CHEST guideline and expert panel report. Chest. 2016;149(2):315–352. doi:10.1016/j.chest.2015.11.026
   PubMed Web of Science ®Google Scholar
• Rappold JF, Sheppard FR, Carmichael ISP, et al. Venous thromboembolism prophylaxis in the trauma intensive care unit, an American Association for the surgery of trauma critical care committee clinical consensus document. Trauma Surg Acute Care Open. 2021;6(1):e000643. doi:10.1136/tsaco-2020-000643
   Google Scholar
• Sauro KM, Soo A, Kramer A, et al. Venous thromboembolism prophylaxis in neurocritical care patients, are current practices, best practices? Neurocrit Care. 2019;30(2):355–363. doi:10.1007/s12028-018-0614-9
   Web of Science ®Google Scholar
• Liss DB, Mullins ME. Antithrombotic and antiplatelet drug toxicity. Crit Care Clin. 2021;37(3):591–604. doi:10.1016/j.ccc.2021.03.012
   Web of Science ®Google Scholar
• Al Khathaami AM, Al Bdah B, Tarawneh M, et al. Utilization of intravenous tissue plasminogen activator and reasons for nonuse in acute ischemic stroke in Saudi Arabia. J Stroke Cerebrovasc Dis. 2020;29(5):104761. doi:10.1016/j.jstrokecerebrovasdis.2020.104761
   Web of Science ®Google Scholar
• Sherman DG, Albers GW, Bladin C, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study), an open-label randomised comparison. Lancet. 2007;369(9570):1347–1355. doi:10.1016/S0140-6736(07)60633-3
   PubMed Web of Science ®Google Scholar